An Atypical Case of COVID-19 Induced Pancytopenia, Rhabdomyolysis and Myocarditis
1Internal Medicine, Apogee Medical Group, Oregon, USA.
Insights
This case report details a unique severe COVID-19 case presenting with rhabdomyolysis, myocarditis, and pancytopenia. The patient recovered with antiviral and steroid treatment, despite not needing oxygen support.
Area of Science:
- Infectious Diseases
- Critical Care Medicine
- Cardiology
Background:
- Severe acute respiratory distress coronavirus 2 (SARS-CoV-2) causes COVID-19, a leading cause of death in adults over 45 in the US.
- Standard treatments like remdesivir, dexamethasone, and convalescent plasma are recommended for patients needing respiratory support.
- Current guidelines typically reserve these treatments for COVID-19 patients requiring supplemental oxygen.
Observation:
- A severe COVID-19 case is presented with unusual symptoms including rhabdomyolysis, myocarditis, and pancytopenia.
- The patient required hospitalization due to the severity of these complications.
- Notably, the patient did not require any form of oxygen support during their illness.
Findings:
- Successful treatment was achieved using antiviral medications and steroids.
- The patient experienced clinical resolution following this therapeutic approach.
- This case highlights an atypical presentation of severe COVID-19.
Implications:
- This case suggests that severe COVID-19 with specific complications may be treatable with antivirals and steroids, even without respiratory support.
- It broadens the understanding of COVID-19 clinical presentations and treatment responses.
- Further research may explore tailored treatment strategies for non-hypoxemic severe COVID-19 cases.
Abstract:
Severe acute respiratory distress coronavirus 2 (SARS-CoV-2) virus is responsible for the current pandemic - coronavirus disease 2019 (COVID-19) plaguing the world. It began spreading as early as January 2020 in the United States (US) and has recently become the leading cause of death amongst adults over 45 years of age. Much of its clinical presentation is already known, and there have been advances in its successful treatment with a food and drug administration (FDA) approved antiviral medication called remdesivir, and other proven investigational methods with clinical benefits including dexamethasone and COVID-19 antibody transfusion called convalescent plasma therapy. However, the recommendations for their use include COVID-19 confirmed patients requiring supplemental oxygen or other forms of respiratory support. In this case report, we describe in detail a unique case of severe COVID-19 infection that did not require any form of oxygen support but was treated successfully with antiviral medications and steroids. The purpose of this report is to highlight in detail an unusual COVID-19 presentation with rhabdomyolysis, myocarditis, and pancytopenia severe enough to require hospitalization and treatment with proven COVID-19 therapy to achieve clinical resolution.
More Related Videos
Related Concept Videos
01:27Myocarditis II: Clinical Features and Diagnostic Tests
01:21Myocarditis I: Introduction
01:14Myocarditis III: Medical Management
01:22Myocarditis IV: Nursing Management
01:25Cardiomyopathy I: Introduction and Classification
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy